A Long-Term Study of the Diversity of OXA-48-Like Carbapenemase-Producing Bacterial Strains in Infected Patients and

Paul-Louis Woerther1, Taha Jardak1, Inès Ben Hassine1

  • 11 Department of Microbiology, Gustave Roussy Cancer Campus , Villejuif, France .

Microbial Drug Resistance (Larchmont, N.Y.)
|July 15, 2017
PubMed
Abstract

Insights

OXA-48 carbapenemases are spreading in French hospitals. This study found diverse bacterial strains and plasmids carrying these resistance genes, highlighting a high risk of dissemination and potential endemicity.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Biology

Background:

  • OXA-48 carbapenemases have emerged and spread globally.
  • Understanding their diversity in hospital settings is crucial for infection control.

Purpose of the Study:

  • To assess the diversity of OXA-48-producing bacterial strains and plasmids.
  • To investigate strains isolated from patients in three Paris-area hospitals.

Main Methods:

  • Included all identified OXA-48-like strains.
  • Performed gene identification (OXA-48-like, ESBLs) and strain fingerprinting (E. coli, K. pneumoniae).
  • Assessed blaOXA-48 genetic environments and plasmid backbones.

Main Results:

  • Studied 68 strains from 30 patients across seven enterobacterial species.
  • Identified OXA-48 (62 isolates), OXA-204 (3 isolates), and OXA-401 (3 isolates).
  • Found high strain diversity within and between patients; identified 5 plasmid patterns.

Conclusions:

  • OXA-48 carbapenemases exhibit high dissemination potential due to transferability.
  • These enzymes may become endemic in France, necessitating ongoing surveillance.